Search results for "PROGNOSIS"

showing 10 items of 2052 documents

Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure

2020

Background: Plasma amino-terminal pro-B-type natriuretic peptide and antigen carbohydrate 125 levels are positively associated with a higher risk of adverse clinical outcomes in acute heart failure. As a proxy of congestion, antigen carbohydrate 125 has also been proposed as a right-sided heart failure marker. Thus, we aimed to determine in this population the main factors – including echocardiographic right-sided heart failure parameters – associated with antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide. Methods and results: We prospectively included 2949 patients admitted with acute heart failure. Amino-terminal pro-B-type natriuretic peptide and antigen carbohy…

Malemedicine.medical_specialtymedicine.drug_classacute heart failureAmino terminalCa 125 antigen030204 cardiovascular system & hematologyCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicineAntigenInternal medicineNatriuretic Peptide BrainNatriuretic peptidemedicineHumans030212 general & internal medicineProspective Studiesright-sided heart failureProtein PrecursorsAgedHeart Failurebusiness.industryGeneral MedicineCarbohydratemedicine.diseasePrognosisPeptide FragmentsEndocrinologyEchocardiographyNT-proBNPHeart failureCA-125 AntigenAcute DiseaseDisease ProgressionFemaleAntigen carbohydrate 125Cardiology and Cardiovascular MedicinebusinessRight-sided heart failureBiomarkersFollow-Up Studies
researchProduct

N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention fo…

2015

Contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) is frequent and associated with long-term renal impairment and mortality. Early markers of CIN are needed to improve risk stratification. We aimed to assess whether N-terminal fragment of pro B-type natriuretic peptide (Nt-proBNP) could be associated with CIN. From the French regional RICO survey, all the consecutive patients who underwent primary PCI for STEMI, from January 1, 2001, to December 3, 2013, were included. Nt-proBNP circulating levels were assessed on admission. CIN was defined as an increase in serum creatinine26.5 μmol/L or50% within 48 to 7…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentPopulationContrast-induced nephropathyMyocardial InfarctionContrast MediaRisk AssessmentCohort StudiesPercutaneous Coronary InterventionRisk FactorsInternal medicineNatriuretic Peptide BrainNatriuretic peptidemedicineDiabetes MellitusHumanscardiovascular diseasesMyocardial infarctionProspective StudieseducationProspective cohort studyAgedAged 80 and overeducation.field_of_studybusiness.industryAge FactorsPercutaneous coronary interventionOdds ratioAcute Kidney InjuryMiddle Agedmedicine.diseasePrognosisPeptide Fragmentssurgical procedures operativeCase-Control StudiesConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersThe American journal of cardiology
researchProduct

Differential Effect of Glycosylated Hemoglobin Value and Antidiabetic Treatment on the Risk of 30-day Readmission Following a Hospitalization for Acu…

2015

In patients with heart failure and type 2 diabetes, low glycosylated hemoglobin has been related with higher risk of mortality but information regarding morbidity is scarce. We sought to evaluate the association between glycosylated hemoglobin and 30-day readmission in patients with type 2 diabetes and acute heart failure.Glycosylated hemoglobin was measured before discharge in 835 consecutive patients with acute heart failure and type 2 diabetes. Cox regression analysis adapted for competing events was used.Mean (standard deviation) age was 72.9 (9.6) years and median glycosylated hemoglobin was 7.2% (6.5%-8.0%). Patients treated with insulin or insulin/sulfonylurea/meglitinides were 41.1%…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentType 2 diabetesGastroenterologyPatient ReadmissionRisk AssessmentInternal medicineDiabetes mellitusmedicineHumansHypoglycemic AgentsAgedRetrospective StudiesGlycated HemoglobinHeart FailureProportional hazards modelbusiness.industryInsulinHazard ratioGeneral Medicinemedicine.diseasePrognosisSulfonylureaConfidence intervalPatient DischargeSurvival RateEndocrinologyDiabetes Mellitus Type 2SpainHeart failureAcute DiseaseFemalebusinessFollow-Up StudiesRevista espanola de cardiologia (English ed.)
researchProduct

Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study.

2017

Background In ST ‐segment–elevation myocardial infarction ( STEMI ), troponins are not needed for diagnosis: symptoms and ECG data are sufficient to activate percutaneous coronary intervention. This study explored the prognostic value of new‐generation troponins in a real‐life cohort contemporarily treated for STEMI . Methods and Results We studied 1260 consecutive patients with primary STEMI treated with percutaneous coronary intervention between February 22, 2011, and August 31, 2015. We collected data on clinical characteristics and major adverse cardiovascular and cerebrovascular events ( MACCEs ) at 30 days and 1 year. Peak high‐sensitivity troponin T and sensitive‐contemporary tropon…

Malemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyVentricular Function Left03 medical and health sciencesElectrocardiography0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsIschemiaInternal medicineCardiovascular DiseaseST segmentMedicineHumansCoronary Heart Disease030212 general & internal medicineMyocardial infarctionST‐segment–elevation myocardial infarctionAgedRetrospective StudiesOriginal ResearchAged 80 and overbiologybusiness.industrytroponinPercutaneous coronary interventionMiddle Agedmedicine.diseasePrognosisTroponinmyocardial infarctionbiology.proteinCardiologyST Elevation Myocardial InfarctionFemaleMortality/SurvivalCardiology and Cardiovascular MedicinebusinessValue (mathematics)BiomarkersJournal of the American Heart Association
researchProduct

Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention

2007

The aim of our study was to evaluate, in patients with proven coronary artery disease (CAD) and treated with elective percutaneous coronary intervention (PCI), whether the coexistence of asymptomatic carotid and femoral atherosclerotic lesions would provide prognostic information in terms of occurrence of restenosis.We studied 104 patients with CAD (M/F=77/27), mean age 60.5+/-9 years. All patients were treated with elective PCI. After PCI the suspicion of restenosis was confirmed by coronary angiography. All patients underwent ultrasound duplex scan of carotid and femoral-popliteal-tibial axis to detect atherosclerotic lesions. According to ultrasound results, patients were classified as n…

Malemedicine.medical_specialtymedicine.medical_treatmentBalloonAsymptomaticPeripheral atherosclerosispercutaneous coronary interventionCoronary RestenosisCoronary artery diseaseRestenosisInternal medicineAngioplastymedicineHumanscardiovascular diseasesAngioplasty Balloon CoronaryAgedPeripheral Vascular Diseasesbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedAtherosclerosisPrognosismedicine.diseasePeripheralConventional PCICardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary Artery Disease
researchProduct

Echocardiographic and lung ultrasound characteristics in ambulatory patients with dyspnea or prior heart failure.

2013

Purpose Lung ultrasound (LUS) represents a novel, noninvasive method in the assessment of extravascular lung water. We investigated the utility of LUS in ambulatory subjects with dyspnea or prior heart failure (HF). Methods We studied 81 ambulatory subjects with HF history or dyspnea who underwent transthoracic echocardiography (TTE) with LUS of 8 zones. Subjects with heart transplantation or pulmonary conditions known to interfere with LUS were excluded. A reviewer blinded to the clinical data performed echocardiographic measurements and quantified B-lines (reverberation artifacts arising from the pleural line). Results Of 81 subjects, 74 (91%) (median age 66 years, 39% men, median left ve…

Malemedicine.medical_specialtymedicine.medical_treatmentBlood PressureRisk AssessmentSensitivity and SpecificityNuclear Medicine and ImagingInternal medicinemedicine.arterymedicineAmbulatory CareHumansRadiology Nuclear Medicine and imagingSingle-Blind MethodLungDyspnea; Echocardiography; Heart failure; Lung ultrasound; Aged; Ambulatory Care; Blood Pressure; Dyspnea; Echocardiography; Extravascular Lung Water; Female; Heart Failure; Humans; Lung; Male; Middle Aged; Prognosis; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Single-Blind Method; Stroke Volume; Cardiology and Cardiovascular Medicine; Radiology Nuclear Medicine and ImagingAgedHeart transplantationHeart FailureLung ultrasoundEjection fractionbusiness.industryReproducibility of ResultsStroke VolumeStroke volumeMiddle Agedmedicine.diseasePrognosisBlood pressureDyspneaEchocardiographyHeart failureAmbulatoryPulmonary arteryExtravascular Lung WaterCardiologyVentricular pressureFemaleRadiologyCardiology and Cardiovascular MedicinebusinessEchocardiography (Mount Kisco, N.Y.)
researchProduct

Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome

2010

Management of the neck in patients treated with primary chemoradiation for cancer of the laryngopharynx with a clinically positive neck remains an area of controversy. The neck may be managed in 1 of 3 ways: by observation, by planned neck dissection, or by salvage neck dissection. Observation of the neck can be done in patients who have a complete or near-complete response to treatment and have a negative positron emission tomography (PET) scan result. Evidence for this approach comes from recent studies that have reported low regional recurrence rates.1–6 Planned neck dissection was carried out in the past in patients with N2 and N3 neck disease irrespective of the response to chemoradiat…

Malemedicine.medical_specialtymedicine.medical_treatmentSettore MED/19 - Chirurgia PlasticaPhysical examinationKaplan-Meier EstimateArticlemedicineCarcinomaHumanschemoradiationLaryngeal NeoplasmsRetrospective Studiesmedicine.diagnostic_testbusiness.industryCancerPharyngeal NeoplasmsRetrospective cohort studyNeck dissectionChemoradiotherapyMiddle AgedLaryngeal Neoplasmmedicine.diseaseSurgeryOtorhinolaryngologyviable tumorPositron emission tomographyLymphatic MetastasisCarcinoma Squamous CellNeck DissectionFemaleprognosisbusinessChemoradiotherapyFollow-Up StudiesHead & Neck
researchProduct

Frailty and Mortality Outcomes After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.

2017

Abstract Background Frailty has been identified as a risk factor for mortality. However, whether frailty increases mortality risk in patients undergoing percutaneous coronary intervention (PCI) has been controversial. Therefore, we conducted a systematic review and meta-analysis of the frailty measures and mortality outcomes in this setting. Methods PubMed and EMBASE were searched until July 23, 2017 for studies evaluating the association between frailty measures and mortality in individuals who have undergone PCI. Results A total of 141 entries were retrieved from our search strategy. A total of 8 studies involving 2332 patients were included in the final meta-analysis (mean age: 69 years;…

Malemedicine.medical_specialtymedicine.medical_treatmentSubgroup analysisCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk Assessment03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsInternal medicineCause of DeathmedicineHumans030212 general & internal medicineRisk factorGeneral NursingAgedProportional Hazards ModelsFrailtybusiness.industryHealth PolicyMortality rateHazard ratioPercutaneous coronary interventionGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurvival AnalysisConfidence intervalTreatment OutcomeMeta-analysisConventional PCIMultivariate AnalysisFemaleMedical emergencyGeriatrics and GerontologybusinessJournal of the American Medical Directors Association
researchProduct

Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases

2018

International audience; Aims The role of extracorporeal membrane oxygenation (ECMO) remains ill defined in pulmonary embolism (PE). We investigated outcomes in patients with high-risk PE undergoing ECMO according to initial therapeutic strategy. Methods and results From 01 January 2014 to 31 December 2015, 180 patients from 13 Departments in nine centres with high-risk PE were retrospectively included. Among those undergoing ECMO, we compared characteristics and outcomes according to adjunctive treatment strategy (systemic thrombolysis, surgical embolectomy, or no reperfusion therapy). Primary outcome was all-cause 30-day mortality. Secondary outcome was 90-day major bleeding. One hundred a…

Malemedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Embolectomy030204 cardiovascular system & hematologyEmbolectomy03 medical and health sciences0302 clinical medicineReperfusion therapyExtracorporeal Membrane OxygenationFibrinolysismedicineExtracorporeal membrane oxygenationHumans030212 general & internal medicineRetrospective Studiesbusiness.industryRetrospective cohort studyThrombolysisMiddle Agedmedicine.diseasePrognosisPulmonary embolismSurgerySurvival Rate[SDV] Life Sciences [q-bio]surgical procedures operativeEchocardiographyAdjunctive treatmentFemaleFranceCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFollow-Up Studies
researchProduct

Presepsin and Midregional Proadrenomedullin in Pediatric Oncologic Patients with Febrile Neutropenia

2020

Abstract Objective In this study, we investigated the roles of presepsin (PSP) and midregional proadrenomedullin (mr-proADM) in children with febrile neutropenia (FN) due to chemotherapy. Methods We assessed 36 FN episodes in 26 children. Patients were classified into bacteremia (B) and fever of unknown origin (FUO) groups. We evaluated PSP and mr-proADM at admission (T0), after 24/48 h (T1), and after 5 days (T2). Results PSP and mr-proADM levels were elevated at T0 and significantly decreased at T2. mr-proADM levels did not significantly differ between the B and FUO groups. PSP levels significantly differed between the B and FUO groups only at T1. Both PSP and mr-proADM levels at T0 were …

Malemedicine.medical_specialtymedicine.medical_treatmentpediatric.Clinical BiochemistryLipopolysaccharide ReceptorsNeutropeniaAdrenomedullinmr-proADMmalignancieNeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsHumansneutropeniaMedicineBlood cultureProtein PrecursorsFever of unknown originChildFebrile NeutropeniafeverChemotherapymedicine.diagnostic_testReceiver operating characteristicbusiness.industryPresepsinBiochemistry (medical)Age FactorsPrognosismedicine.diseasePeptide FragmentsAdrenomedullinROC CurveoncologicBacteremiaFemalebusinessBiomarkersFebrile neutropeniaLaboratory Medicine
researchProduct